NordiQC welcomes pathologists, technologists, scientists, diagnostic company staff members and others with interest in applied immunohistochemistry (IHC) to join the

4th NordiQC Conference on Applied Immunohistochemistry
arranged in collaboration with the
International Society for Immunohistochemistry and Molecular Morphology

Introduced by international experts and NordiQC specialists, the conference is focused on development and standardization of IHC and related molecular based techniques for tumour classification and precision medicine. Issues of IHC protocol optimization, selection and interpretation of positive and negative controls, and external quality assessment (EQA) / proficiency testing will be highlighted. Special emphasis is given on up-to-date pathological approach to new diagnostic and predictive biomarkers, particularly in tumours of breast, lung, digestive system, kidney, urinary tract, prostate, testis and soft tissues.

IHC is an increasingly important ancillary tool in diagnostic pathology, but IHC is far from standardized. We must devote our efforts to developing international standards in our daily practice as well as in science for the overall benefit of patients. As the role of IHC is changing from an ancillary diagnostic technique to that of a stand-alone diagnostic method, the results of which determine treatment approach, standardization of preanalytical, analytical and postanalytical methods have become even more important, as the results emanating from different laboratories must be directly comparable.

This conference gives you the opportunity to learn about real-world, practical applications in the ever-evolving field of applied immunohistochemistry.

Also see the programme, abstracts etc. from the 3nd NordiQC conference on:

http://www.nordiqc2017.dk

http://nordiqc2020.dk/wp-content/uploads/NordiQC_Conference_programme_2020_30.09.2019.docxClick on Speakers and select a speaker to open and download presentations (pdf-files)